Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings
Beginning balance (in shares) at Feb. 02, 2019   238,100,000          
Beginning balance at Feb. 02, 2019 $ 5,642.9 $ 2.4 $ 2,602.7 $ (38.3) $ 3,076.1 $ (65.3) $ (65.3)
Statement of Stockholders' Equity [Roll Forward]              
Net income 704.0       704.0    
Total other comprehensive income (loss) (0.9)     (0.9)      
Issuance of stock under Employee Stock Purchase Plan (in shares)   100,000          
Issuance of stock under Employee Stock Purchase Plan 7.5   7.5        
Exercise of stock options (in shares)   0          
Exercise of stock options 4.9   4.9        
Stock-based compensation, net (in shares)   400,000          
Stock-based compensation, net $ 28.2   28.2        
Repurchase of stock (in shares) (1,967,355) (1,900,000)          
Repurchase of stock $ (200.0)   (200.0)        
Ending balance (in shares) at Nov. 02, 2019   236,700,000          
Ending balance at Nov. 02, 2019 6,121.3 $ 2.4 2,443.3 (39.2) 3,714.8    
Beginning balance (in shares) at Aug. 03, 2019   236,800,000          
Beginning balance at Aug. 03, 2019 5,865.7 $ 2.4 2,443.9 (39.6) 3,459.0    
Statement of Stockholders' Equity [Roll Forward]              
Net income 255.8       255.8    
Total other comprehensive income (loss) 0.4     0.4      
Issuance of stock under Employee Stock Purchase Plan (in shares)   0          
Issuance of stock under Employee Stock Purchase Plan 2.3   2.3        
Exercise of stock options (in shares)   0          
Exercise of stock options 0.8   0.8        
Stock-based compensation, net (in shares)   0          
Stock-based compensation, net $ 7.9   7.9        
Repurchase of stock (in shares) (125,048) (100,000)          
Repurchase of stock $ (11.6)   (11.6)        
Ending balance (in shares) at Nov. 02, 2019   236,700,000          
Ending balance at Nov. 02, 2019 6,121.3 $ 2.4 2,443.3 (39.2) 3,714.8    
Beginning balance (in shares) at Feb. 01, 2020   236,700,000          
Beginning balance at Feb. 01, 2020 6,254.8 $ 2.4 2,454.4 (39.8) 3,837.8    
Statement of Stockholders' Equity [Roll Forward]              
Net income 839.1       839.1    
Total other comprehensive income (loss) (0.8)     (0.8)      
Issuance of stock under Employee Stock Purchase Plan (in shares)   100,000          
Issuance of stock under Employee Stock Purchase Plan 7.6   7.6        
Exercise of stock options (in shares)   100,000          
Exercise of stock options 6.7   6.7        
Stock-based compensation, net (in shares)   400,000          
Stock-based compensation, net $ 53.7   53.7        
Repurchase of stock (in shares) (2,154,304) (2,100,000)          
Repurchase of stock $ (200.0)   (200.0)        
Ending balance (in shares) at Oct. 31, 2020   235,200,000          
Ending balance at Oct. 31, 2020 6,961.1 $ 2.4 2,322.4 (40.6) 4,676.9    
Beginning balance (in shares) at Aug. 01, 2020   237,300,000          
Beginning balance at Aug. 01, 2020 6,813.6 $ 2.4 2,505.5 (41.2) 4,346.9    
Statement of Stockholders' Equity [Roll Forward]              
Net income 330.0       330.0    
Total other comprehensive income (loss) 0.6     0.6      
Issuance of stock under Employee Stock Purchase Plan (in shares)   0          
Issuance of stock under Employee Stock Purchase Plan 2.5   2.5        
Stock-based compensation, net (in shares)   0          
Stock-based compensation, net $ 14.4   14.4        
Repurchase of stock (in shares) (2,154,304) (2,100,000)          
Repurchase of stock $ (200.0)   (200.0)        
Ending balance (in shares) at Oct. 31, 2020   235,200,000          
Ending balance at Oct. 31, 2020 $ 6,961.1 $ 2.4 $ 2,322.4 $ (40.6) $ 4,676.9